Hypera (HYPE3) Q2 2025 earnings summary

Executive summary

• Sell-out grew 5.5% year-over-year in Q2 2025, accelerating to 8.4% in May–July, outpacing the addressable market and driven by market recovery, new product launches, and increased digital marketing investments.

• Working capital optimization completed, reducing average receivable term from 116 to 60 days and working capital investment from 49% to 32% of net revenue, the lowest in company history.

• Net revenue reached R$2,153.9 million in 2Q25, down 1.6% year-over-year, impacted by lower non-retail sales and working capital optimization.

• New Board of Directors and controlling block established, with a new shareholders' agreement to strengthen governance and strategic decision-making.

• Interest on equity of R$185.1 million (R$0.29/share) declared in 2Q25.

Financial highlights

• Gross profit was R$1,295.1 million, with a gross margin of 60.1%, down 0.8 p.p. year-over-year due to product mix changes.

• EBITDA from continuing operations was R$725.4 million, margin at 33.7%, down 0.8 p.p. year-over-year.

• Net income from continuing operations was R$426.1 million, a 13.4% decrease year-over-year.

• Operating cash flow was R$443 million, slightly above expectations; free cash flow was R$204.6 million, down 55.4% year-over-year.

• Net debt after hedge ended at R$7,614.6 million, 2.6x annualized EBITDA.

Outlook and guidance

• Sell-out growth of around 8% anticipated to be maintained for the remainder of 2025; 2026 expected to be similar, pending budget process.

• Expectation of strong EBITDA to cash conversion in the second half, benefiting from lower working capital investments.

• Focus remains on deleveraging in the short term, with M&A considered for the mid- to long-term.

• Continued investment in innovation, marketing, and production capacity to support medium- and long-term growth.

• Further inventory reductions possible as new policies are assessed.